Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/molecules25235695

http://scihub22266oqcxt.onion/10.3390/molecules25235695
suck pdf from google scholar
33287144!7730706!33287144
unlimited free pdf from europmc33287144    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33287144      Molecules 2020 ; 25 (23): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge #MMPMID33287144
  • Picarazzi F; Vicenti I; Saladini F; Zazzi M; Mori M
  • Molecules 2020[Dec]; 25 (23): ä PMID33287144show ga
  • The RNA-dependent RNA polymerase (RdRp) is an essential enzyme for the viral replication process, catalyzing the viral RNA synthesis using a metal ion-dependent mechanism. In recent years, RdRp has emerged as an optimal target for the development of antiviral drugs, as demonstrated by recent approvals of sofosbuvir and remdesivir against Hepatitis C virus (HCV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respectively. In this work, we overview the main sequence and structural features of the RdRp of emerging RNA viruses such as Coronaviruses, Flaviviruses, and HCV, as well as inhibition strategies implemented so far. While analyzing the structural information available on the RdRp of emerging RNA viruses, we provide examples of success stories such as for HCV and SARS-CoV-2. In contrast, Flaviviruses' story has raised attention about how the lack of structural details on catalytically-competent or ligand-bound RdRp strongly hampers the application of structure-based drug design, either in repurposing and conventional approaches.
  • |Amides/chemistry/pharmacology[MESH]
  • |Antiviral Agents/*chemistry/*pharmacology[MESH]
  • |Coronavirus/drug effects/enzymology/genetics[MESH]
  • |Drug Design[MESH]
  • |Enzyme Inhibitors/chemistry/pharmacology[MESH]
  • |Flavivirus/drug effects/enzymology/genetics[MESH]
  • |Hepacivirus/drug effects/enzymology/genetics[MESH]
  • |Humans[MESH]
  • |Pyrazines/chemistry/pharmacology[MESH]
  • |RNA Virus Infections/epidemiology[MESH]
  • |RNA Viruses/drug effects/*enzymology[MESH]
  • |RNA-Dependent RNA Polymerase/antagonists & inhibitors/*chemistry/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box